VeriMomisobutylamido thiazolyl resorcinol hamilelikte güvenli mi?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment for isobutylamido thiazolyl resorcinol (Thiamidol) was identified; clinical topical studies (0.15–0.2% formulations) report efficacy and skin tolerability but no reproductive or teratogenic findings, so default hazard/mechanism = 0. Topical use gives low but measurable exposure (clinical topical use data). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/33559186/?utm_source=openai))
Pregnancy-safe products containing isobutylamido thiazolyl resorcinol
Related ingredients
Frequently asked questions
- isobutylamido thiazolyl resorcinol hamilelikte güvenli mi?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment for isobutylamido thiazolyl resorcinol (Thiamidol) was identified; clinical topical studies (0.15–0.2% formulations) report efficacy and skin tolerability but no reproductive or teratogenic findings, so default hazard/mechanism = 0. Topical use gives low but measurable exposure (clinical topical use data). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/33559186/?utm_source=openai))
- isobutylamido thiazolyl resorcinol emzirirken güvenli mi?
- No data on lactation transfer or breastmilk levels and no reproductive or developmental signals in available literature. By default hazard/mechanism = 0; topical application gives low but measurable exposure so exposure = 1 in breastfeeding context absent data. Clinical safety reports do not indicate systemic developmental effects. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/33559186/?utm_source=openai))
- isobutylamido thiazolyl resorcinol bebek cildi için güvenli mi?
- No infant-specific safety or developmental studies found. Following the scoring rules, because adult topical exposure is low but measurable (e=1) and infant skin has higher absorption, exposure for baby skin is increased by +1 to e=2. No evidence found to increase hazard or mechanism scores. Note: there are case reports of allergic contact dermatitis in adults but no infant-specific adverse reports. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/40456229/?utm_source=openai))
- VeriMom isobutylamido thiazolyl resorcinol nasıl puanlıyor?
- VeriMom isobutylamido thiazolyl resorcinol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte isobutylamido thiazolyl resorcinol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.